Let us not forget the important role of academic spinouts in innovating across the modalities.

Researchers use AI to produce synthetic pharmacokinetic data.

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

Researchers demonstrate how extracellular vesicles derived from mesenchymal stem cells can increase survival chances.

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

The political situation in the US and its impact on science and medicine is changing rapidly. Here’s a quick look at the latest developments.

ADCs have shown their promise, but the next step is realizing their potential.

Advances in computer simulations allow researchers to look at G protein-coupled receptors in more detail than ever before.

FDA to phase out mandatory animal testing with human-relevant methods for drug development